Combination Chemotherapy in Treating Men With Germ Cell Cancer
NCT00003643
Unknown
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which regimen of combination chemotherapy may be more effective for germ cell cancer. PURPOSE: This randomized phase II/III trial is studying two different regimens of combination chemotherapy and comparing how well they work in treating men with germ cell cancer.
Gender:
MALE
Ages:
Between 16 years and 50 years
Trial Updated:
03/05/2012
Locations: Ludwig Boltzmann Institute for Applied Cancer Research at Kaiser Franz Josef Hospital, Vienna, Not set +68 locations
Conditions: Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor
Register for Updates
Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries
NCT00148356
Completed
The purpose of this study is to demonstrate the safety and efficacy of the ZoMaxx drug-eluting stent in patients with blockage of native coronary arteries. The study is designed to demonstrate non-inferiority to the TAXUS Express2 Paclitaxel-Eluting Stent that has proven superior to bare metal stents and is a recognized standard of care.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/31/2011
Locations: St. Vincent's Hospital, Fitzroy, Victoria +28 locations
Conditions: Coronary Disease, Coronary Artery Disease, Coronary Restenosis
Register for Updates
Phase I Study in Patients With Solid Tumours
NCT00496028
Completed
This study will comprise 2 parts, a dose escalation phase and a dose expansion phase. The 2 phases are part of a single study and described by this single protocol. Patients entered into the dose escalation phase will not be entered into the expansion phase. All subjects must be suitable for treatment with either carboplatin and/or paclitaxel.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
09/21/2010
Locations: Research Site, Paris, Not set +6 locations
Conditions: Neoplasms
Register for Updates
SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries
NCT00114972
Unknown
The SYNTAX trial is designed to determine the best treatment for patients with complex coronary disease (blocked or narrowed arteries in both the right and left sides of the heart) by randomizing patients to receive either percutaneous coronary intervention (PCI) with polymer-based paclitaxel-eluting TAXUS stents or to coronary artery bypass surgery (CABG).
Gender:
ALL
Ages:
21 years and above
Trial Updated:
05/27/2010
Locations: Mercy General Hospital, Sacramento, California +105 locations
Conditions: Coronary Artery Disease
Register for Updates
DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer
NCT00024375
Unknown
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of DHA-paclitaxel in treating patients who have metastatic pancreatic cancer.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/17/2009
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland +8 locations
Conditions: Pancreatic Cancer
Register for Updates